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Acceptance and commitment therapy
for chronic pain: protocol of a systematic
review and individual participant data
meta-analysis
Jiaxi Lin1* , Whitney Scott2, Lewis Carpenter2, Sam Norton2, Matthias Domhardt3, Harald Baumeister3 and
Lance M. McCracken4
Abstract
Background: Acceptance and commitment therapy (ACT) can be effective in treating chronic pain. Despite evidence
supporting the effectiveness of ACT, uncertainties remain regarding which subgroups in the chronic pain population
are likely to benefit most and least. This protocol describes the application for two meta-analytic approaches, one at
the level of individual participant data and the other at the level of aggregated data, from randomized controlled trials
of ACT for chronic pain (ACT-CP-MA).
Methods: We will systematically conduct literature searches in CENTRAL, MEDLINE, EMBASE, PsycINFO, and trial registers.
Two reviewers will independently select studies for inclusion and data extraction. ACT-CP-MA will include randomized
controlled trials with ACT for chronic pain compared to control conditions for adults (≥ 18 years) with chronic
pain (> 3 months). We will invite the authors of all eligible trials to share individual participant data. Outcomes
will include standardized measures of pain interference, pain intensity, depression, anxiety, health-related quality
of life, participants’ rating of overall improvement, and ACT-related process variables. Using the Cochrane
Collaboration’s tool and GRADE, reviewers will independently check for risk of bias, quality of evidence, and
strength of recommendations. In the individual participant data meta-analysis, we will use a one-step approach
where participants are clustered with studies and data from all studies are modeled simultaneously. For analyses,
we will use mixed-effects models. Additionally, we will employ a meta-analysis with aggregate data and compare
the results of both meta-analyses.
Discussion: This collaborative meta-analysis of individual participant data from randomized controlled trials of
ACT for chronic pain versus control conditions will demonstrate how the known benefits of ACT for chronic pain
vary across different subtypes of the chronic pain population. The results of the meta-analyses will be based on a
comprehensive search of multiple databases and will help to inform future clinical trials and decision-making on
the use of ACT in chronic pain and improve the quality, design, and reporting of future trials in this field.
Systematic review registration: PROSPERO CRD42019120901.
Keywords: Individual participant data meta-analysis, Acceptance and commitment therapy, Chronic pain, Subgroups
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Background
Chronic pain is defined as pain lasting more than
3 months and can be seen as a disease in its own right [1].
The prevalence rates of chronic pain are in the range of
27% in European countries [2], equivalent to international
estimates [3, 4]. This condition is associated with a high
disease burden in terms of personal suffering, low quality
of life, and high economic costs, and is considered as a
major health care problem worldwide [5, 6]. According to
the Global Burden of Disease Study of 2017 [7], over the
28-year period from 1990 to 2017, low back pain, head-
ache disorders, and depressive disorders have prevailed as
three of the top four leading causes of years lived with
disability worldwide.
The biopsychosocial approach is regarded as the gold
standard in the treatment of chronic pain [8, 9]. Psycho-
logical interventions, such as the acceptance and com-
mitment therapy (ACT), constitute a core component
within this approach. ACT aims to increase openness to
difficult experiences such as pain, as well as awareness
of behavioral options, and to facilitate behavior change
processes that are in line with personal life values in the
presence of these experiences [10, 11]. Various methods
of delivering ACT have been shown to be effective in
treating chronic pain: either as individual face-to-face
intervention (e.g., [12, 13]), group-delivered face-to-face
(e.g., [14–23]), self-help books [24, 25], or Internet-based
delivery [26–30]. The British Pain Society recommends
ACT in the treatment of chronic pain [31] and although
ACT has also been implemented in public care for
patients with chronic pain in some countries, consi-
derable barriers to implement psychological interven-
tions have been observed [32].
The effectiveness of ACT for improving pain-related
outcomes has been supported in several (non-Cochrane)
reviews, with the consistent conclusion that ACT
appears to be equally effective as traditional cognitive
behavior therapy [33–36]. The latest meta-analysis found
small to large effect sizes for measures of functioning,
anxiety, and depression (SMD= − 0.45, − 0.57 and − 0.84,
respectively) [35]. No treatment effects were observed
with regard to the outcomes for quality of life and pain
intensity [35]. This evidence-base suggests that the effects
of ACT, as with most treatments for chronic pain, need to
be improved. One way to do so is to broaden our under-
standing of which patient characteristics and conditions as
well as mode of treatment delivery (e.g., internet-based or
face-to-face) are associated with treatment effects and
which are not [32, 35, 37, 38]. Hence, examining effect
moderators of chronic pain treatment would greatly facili-
tate patient tailored interventions and constitute a crucial
step forward in the management of chronic pain.
A few systematic reviews have already investigated
this issue. There is one review focusing on ACT and
mindfulness-based approaches by Gilpin and colleagues
[39], and reviews on other psychological and non-psy-
chological pain approaches [40–42], and with regard to
certain specified aspects, such as fear-avoidance beliefs
[43]. In the review by Gilpin and colleagues [39], some
evidence was found that higher psychological distress or
history of depression is associated with greater improve-
ments in mindfulness-based interventions. Equivalent to
an earlier review on behavioral and cognitive-behavioral
interventions [42], this review found that relationships
between demographic variables and treatment outcome
were inconsistent and not significant in most cases [39].
In the review on self-management programs in musculo-
skeletal pain [41], one study showed that higher levels of
depression at baseline predicted poorer physical function-
ing at 6 months [44]. In patients with low back pain, high
fear-avoidance beliefs were associated with more pain
and/or disability and lower likelihood to return to work
[43]. In general, most of the trials reviewed did not include
subgroup analyses and most of the trials with these
analyses lacked the power to find reliable treatment effects
for specific subgroups. Hence, the evidence-base of treat-
ment moderators is inconsistent. Also, due to the high
heterogeneity of the included studies, meta-analyses (MA)
of aggregated data (AD, hereinafter referred as AD-MA)
were not conducted in the above reviews. Consequently,
the current state of scientific knowledge on treatment
predictors and moderators is fragmented, inconclusive,
and therefore difficult to interpret.
A meta-analysis of individual participant data (IPD, here-
inafter referred as IPD-MA) may therefore be a reliable
method to overcome high heterogeneity across trials. This
not only refers to methodological aspects (e.g., choice of
predictor, moderator, and outcome variables, length of
follow-up) but also to aspects of the study population, such
as gender or a specific pain condition. By using IPD,
standardization of analyses and reporting of results across
studies, direct derivation of outcomes can be facilitated,
independent of how these were reported [45]. IPD also
increases the power to detect differential treatment effects
between individual participants, allowing for additional
examination of who is most likely to respond with a wider
range of statistical analyses. Given these reasons and the
advantages over AD-MAs, the IPD-MA has been described
as the gold standard of systematic reviews [46].
Therefore, the present project aims to conduct an
IPD-MA and an AD-MA to systematically review studies
on ACT for chronic pain (ACT-CP-MA) in order to
provide comprehensive insights into the effects of ACT
for chronic pain. In detail, ACT-CP-MA aims
1. To provide an updated AD-MA on the effects
of ACT on pain interference and other key
outcomes in individuals with chronic pain.
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2. To conduct an IPD-MA to evaluate the effects of
ACT on pain interference and other key outcomes
of individuals with chronic pain.
3. To identify
(a) individual-related effect modifiers (predictive
markers): socio-demographic and pain-related
characteristics, ACT-related processes,
(b) treatment-related effect modifiers: traditional
one-to-one face-to-face ACT, group-delivered
face-to-face ACT, or internet intervention,
number of sessions, and
(c) study-related effect modifiers (recruitment
strategy, quality of assessment, control groups)
factors that moderate treatment effects of ACT in
chronic pain in the included randomized controlled
trials (RCTs). For these analyses based on IPD, we will
derive various factors from ACT theory and research on
chronic pain and formulate specific research questions
[47–51].
Due to the complexity of this research field, this study
protocol describes the general aims of ACT-CP-MA.
The specific research questions for the moderator
analyses will be presented and reported separately in
respective future publications.
Methods
We will conduct ACT-CP-MA in accordance with the
Preferred Reporting Items for Systematic reviews and
Meta-Analyses statement (PRISMA [52], see PRISMA-P
checklist in Additional file 1) and the extension of
PRISMA for IPD-MAs [53]. Studies will be selected
according to the PICOS criteria [54] outlined in the fol-
lowing and summarized in Table 1.
Participants
The population of interest consists of adult persons (≥
18 years) with chronic (duration > 3 months), non-
malignant pain. If a study has included both adolescents
and young adults over the age of 18 years, this study will
be excluded since it can be assumed that the treatment
settings for adults and children/adolescents/young adults
can be very heterogenous. Inclusion of primary studies
will not be further limited to specific clinical subgroups
in order to increase power and the ability to inspect the
role of individual and study differences.
Intervention
In this review, we will exclusively focus on ACT-based
interventions. Consistent with a recent review on ACT
for chronic pain [35], studies will be included only if the
intervention explicitly uses the full ACT model. In
accordance with a recent review on predictors and mo-
derators in ACT and mindfulness-based approaches [39],
the high heterogeneity in the theoretical base of treat-
ment and therapeutic mechanisms can cause differences
in individual responsiveness and may explain inconsis-
tencies between studies. Consequently, we will exclude
studies with purely mindfulness-based interventions. All
ACT interventions regardless of their mode of delivery
will be included in the review (e.g., face-to-face, indivi-
dual, group, self-help book, internet intervention).
Comparator(s)
We will include trials if the comparison group received
either an active treatment for chronic pain (ACT or
non-ACT) or a control condition, i.e., treatment as
Table 1 PICOS elements of the study inclusion criteria
Participants Adult persons (≥ 18 years) with chronic, non-malignant pain (duration > 3 months)
Intervention Pain-specific ACT, different modes of delivery e.g.
• Face-to-face individual
• Face-to-face group
• Self-help book with/without guidance
• Self-help internet intervention with/without guidance
Comparator • Active chronic pain-specific (ACT or non-ACT) treatment
• Wait-list
• Treatment as usual
• Attention control
• Psychological placebo
• No treatment
Outcomes • Pain specific: interference and intensity
• Emotional functioning: depression and anxiety
• Health-related quality of life
• Participants’ rating of overall improvement
• ACT specific: pain acceptance, psychological flexibility
Study design Randomized controlled trials with ethics approval
ACT acceptance and commitment therapy
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usual, psychological placebo, attention control condition,
waitlist control, or no treatment.
Outcomes
Our selection of outcomes is based on recommendations
from the Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials (IMMPACT; [50, 51, 55]) as
well as on theoretically relevant aspects of ACT [39, 56–62].
Pain-specific outcomes
IMMPACT recommends the use of the Multidimen-
sional Pain Inventory (MPI; [63]) or interference scale of
the Brief Pain Inventory (BPI; [64]) as validated self-
report questionnaires for pain interference. In case of
multiple outcome measures for pain interference, we will
favor the MPI due to the higher number of items (nine
in the MPI versus even in the BPI) and given that it is
the most frequently used outcome measure across
studies. If none of these questionnaires were used in the
studies, comparable validated self-report questionnaires,
such as the pain disability index (PDI; [65]) will be used
(randomly in case of multiple measure). The scores of
different questionnaires will be standardized to allow all
measures of pain to be modeled together.
The following secondary outcome measures must be
assessed by standardized measures:
 Pain intensity (numeric or visual analogue scales)
 Depression (e.g., Patient Health Questionnaire
(PHQ-9 [66]) or The Hospital Anxiety Depression
Scale (HADS [67]))
 Anxiety (e.g., HADS [67], Generalized Anxiety
Disorder-7 scale [68])
 Health-related quality of life (HrQol; e.g., short form
12-item survey (SF-12 [69]), Assessment of Quality of
Life (AQoL-8D [70]), or the EuroQol (EQ-5D [71]))
 Participants’ rating of overall improvement (e.g.,
Patient Global Impression of Change (PGIC [72]))
 ACT-related variables (e.g., psychological flexibility
the Acceptance and Action Questionnaire-II
(AAQ-II [73]), the Chronic Pain Acceptance
Questionnaire (CPAQ [74]), or the Committed
Action Questionnaire (CAQ [60]))
Predictors and moderators of treatment outcome
We differentiate between individual predictors, treatment-
related moderators, and study-level moderators for treat-
ment outcome. Individual predictors for treatment
outcome are variables assessed at baseline before the
start of the treatment. The following factors are defined as
potential individual predictors for treatment outcome in
this study: socio-demographic factors (age, gender,
employment status, level of education, relationship status,
comorbid somatic/psychiatric conditions), pain-related
factors (pain duration, baseline pain interference, and
intensity), and baseline ACT-related factors (e.g., pain
acceptance). We identified these factors to be potential
predictors of treatment effect from single studies and
reviews with inconsistent findings [32, 35, 38–41, 75–81].
Treatment-related factors are the proportion of intended
number of sessions attended.
Study-level moderators for treatment outcome include
intervention characteristics (i.e., mode of intervention
delivery, number of modules/sessions, level of guidance)
and study characteristics (i.e., recruitment setting, such
as open recruitment through self-referral, or recruitment
in primary, secondary or tertiary care). We will also
collect information on adverse events and adherence to
the treatment as reflected by the percentage of com-
pleted modules in each study-specific treatment. We will
summarize these data on a descriptive level, given that
these aspects are not expected to be reported in all iden-
tified studies and as adherence can only be observed in
the interventions groups.
Study design
Randomized controlled trials (RCTs) of any length of
follow-up and any setting will be included if reported.
We will not apply any exclusion based on publication
status, date, or type. We will only use data from stud-
ies that received ethics approval and that are pub-
lished in English.
Study identification and selection
To minimize publication bias, we will search for pub-
lished and unpublished trials. For the published trials,
we will search for RCTs of ACT for chronic pain in the
following databases using medical subject headings
(MeSH): (1) Cochrane Central Register of Controlled
Trials (CENTRAL), (2) MEDLINE, (3) EMBASE, and (4)
PsycINFO. We will use RCT filters for MEDLINE and
EMBASE and applied adaptations of these to the other
databases. Two reviewers (JL and WS) developed the
MEDLINE strategy. The search strategy for the literature
search is included in Additional file 2.
Additionally, we will search in the International Standard
Randomized Controlled Trial Number register (ISRCTN),
WHO International Clinical Trials Registry Platform
(ICTRP), ClinicalTrials. Gov, and PROSPERO and examine
reference lists of all references of included trials and
reviews to identify other potentially relevant studies.
Further, we will contact all corresponding authors of
included trials and asked about other RCTs, published or
unpublished, which might be eligible for the review.
These strategies are important in order to find eligible
“gray literature” (i.e., unpublished trials, trials, and tri-
als reported as meeting abstracts, book chapters, and
letters [82]).
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Two reviewers (JL and WS) will independently select
relevant studies for inclusion. First, we will examine a
list of titles and abstracts. If title and abstract contain
sufficient information to determine exclusion, we will
exclude the respective article. For all remaining articles,
we will retrieve and review the full text independently.
In addition, we will review all other potentially relevant
articles identified by checking the reference lists or
personal communications. If there are discrepancies
between reviewers at any stage of the process, we will
consult a third reviewer (LM).
Data collection
We will initially contact the corresponding author of
all identified trials to invite them to participate in
ACT-CP-MA and to share their raw data (see
Additional file 3 for contact letter, a modified version of
[83]). This invitation contains a short introduction to
ACT-CP-MA, including the aim, inclusion criteria,
and outcomes as well as a short description of the
ACT-CP-MA procedures. We will offer PIs who have
shared their data to become a co-author in the result
publications. They are also invited to become active
collaborators within the project. If we cannot contact the
corresponding author, we will email all co-authors listed.
If we fail to receive a response to our initial email invita-
tion, we will send reminders after two and if, necessary,
after 4 weeks. If the study investigators are still not
responding or unwilling to contribute their study data, we
will send a final note inquiring why they are unable to
participate. If there is no response after 4 weeks, the trial
will be excluded as “unavailable.”
In order to increase the feasibility of the IPD-MA, we
will provide regular e-mail updates to keep the colla-
borative group up to date and involved. On an online
collaboration platform (trello.com), we will present all
procedures during the acquisition of the data and the
analysis and their respective deadlines so that the
procedures will be transparent to all collaborators.
We will seek from all relevant trials data for all partici-
pants at all assessment times, including those excluded
from the investigators’ own analyses. In order to
minimize the amount of work for study authors, we will
accept databases in all formats. Before transferring the
data, we will ask the investigators to anonymize the data
and to use a password-protected encryption. Once we
have received the original data file, we will archive
the original data as backup and transfer the IPD to a
converted and combined overall dataset with stan-
dardized variables, the ACT-CP-IPD database. For
data harmonization, we will apply the procedures
described in Buffart et al. [84]. We will discuss any
inconsistencies with the original authors and make
corrections when necessary.
For the AD-MA, a standardized data extraction form
has been developed and will be piloted, based on the
template of the Cochrane good practice data extraction
form (Version 4, April 2014, see Additional file 4) to
extract data from the selected studies.
Assessment of risk of bias in included studies
Two reviewers (JL and WS) will independently assess
risk of bias using the Cochrane Risk of Bias assess-
ment tool, focusing on the evaluation of sequence
generation, allocation concealment, blinding (partici-
pants, personnel, and outcome assessors), incomplete
data, selective outcome reporting, and assessing other
biases [85]. Additionally, the researchers (JL and WS)
will assess the evidence profiles for each of the
identified outcomes based on the GRADE (Grading
of Recommendations, Assessment, Development and
Evaluation) approach to reviewing evidence [86–88]. In
case of disagreement between the reviewers, discussions
or consultation of a third reviewer (MD) will take
place. For the trials that were conducted by JL or
WS, MD will assess the risk of bias instead of JL or
WS, respectively. If needed, a statistician (SN or LC)
will be consulted regarding judgments relating to
statistical analyses.
Statistical analysis
Individual participant data meta-analyses
We will perform analyses according to current expert
recommendations for individual participant data meta-
analysis [45, 89]. By using mixed-effects models, we will
apply the one-stage approach IPD-MA based on the com-
bination of all data in a single meta-analysis [89, 90]. In
order to consider clustering effects from study to study,
we will apply a two-level hierarchical structure: the partici-
pants within each trial as level 1 and the trial as level 2.
We will perform all analyses on a modified intention-to-
treat (ITT) basis using a statistical interpolation strategy
for missing data within the mixed-effects model. For this
strategy, we will include all randomized participants with
outcome data.
Using mixed-effects models, we will examine treat-
ment effects on the specified outcomes. With regard
to potential treatment moderators on the outcomes,
we will examine interactions between the intervention and
the above-mentioned individual predictors, treatment-
related moderators, and study-level moderators. For data
management and harmonization, SPSS will be used as
most datasets will be available in SPSS format. Analyses
will be conducted using R (R Foundation for Statistical
Computing, [91]) which offers a wide variety of basic to
advanced statistical and graphical techniques.
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Aggregate data meta-analyses
For those studies where IPD were not provided, a sensitiv-
ity analysis exploring the estimated treatment effect with
AD will be conducted. To estimate the treatment effect of
ACT compared to different control groups, we will calcu-
late the effect sizes (Hedges’ g) [92], which will be pooled
using a random-effects meta-analysis. We will test for
statistical heterogeneity using the Chi2 test (significance
level: 0.1) and I2 statistic on the basis of the Cochrane
Handbook [93] recommendations. To examine publi-
cation bias, we will visually inspect the funnel plot, by
using the trim and fill procedure and Egger’s test of funnel
plot asymmetry [94, 95]. A sensitivity analysis will also be
conducted excluding studies with high risk of bias.
This AD-MA will exclusively examine treatment ef-
fects on the specified outcomes without investigating
potential treatment moderators or predictors. This
decision is based on the lack of studies investigating
these variables in ACT and mindfulness-based treat-
ments for chronic pain as documented in a recent
meta-analysis [39]. Further, for variables measured at
the individual level, the IPD-MA will have considerably
greater power to investigate this research question in
comparison to an AD-MA.
The results with regard to the treatment effects of
both meta-analyses will be compared: By doing this, we
will analyze and discuss potential differences between
studies included in the IPD-MA and those not included.
Discussion
ACT-CP-MA will use a thoroughly defined methodology
and provide an updated review on the effect of ACT for
chronic pain. It will be the first study that comprehensively
examines data with an explorative study approach including
important potential predictor and moderators of treatment
effects. Therefore, it can overcome predefined hypotheses
that were applied in each included primary study and
allows for an overview of factors that may be crucial to
treatment effects observed in ACT for chronic pain.
The central strength of this study lies in the methodo-
logical approach which will use an IPD-MA of random-
ized controlled studies on ACT for chronic pain based on
an extensive search of multiple databases, journals, re-
ferences, and citations. We will deal with a wide array of
outcomes based on theory and experts’ recommendations
as well as with individual-based predictors and treatment-
related moderators of treatment effects. Using the same
systematic procedures, harmonization of variables and
analyses on these variables across multiple studies, we will
provide a consistent evidence synthesis across all variables.
Results of this review will be published in international
medical and psychological journals and presented at na-
tional and international conference meetings following the
PRISMA statement [52, 53].
Limitations
We will possibly face some difficulties in obtaining
original data from all of the identified trials. These
difficulties may result in a bias to the IPD-MA [45].
Therefore, we will additionally conduct an AD-MA
with all identified studies. This AD will provide a
basis for comparisons between the AD-MA and IPD-MA.
Furthermore, we will increase the exchange in the
field of research on ACT and chronic pain in order
to build a collaborative network to facilitate the exchange
of data.
Conclusions
In ACT-CP-MA, we will review RCTs of ACT for chronic
pain and bring together relevant evidence. We will discuss
the findings with regard to future directions of research
on ACT for chronic pain as well as implications for health
care services to help people make well-informed decisions.
The information on different treatment predictors and
moderators may help clinicians match patients most likely
to benefit from ACT with this treatment approach in the
sense of personalized medicine. This will also allow
conclusions on which characteristics of individuals would
best benefit from which form of intervention (face to face,
internet-based, group-based, individual). Thereby, treat-
ment costs may be better controlled by allocating treat-
ment resources where they are likely to be most effective
[42]. Therefore, the results of this review may provide a
basis for treatment guidelines for chronic pain patients
with respect to the provision of ACT and its type of deli-
very. The findings of this study will help researchers to
refine ACT-based interventions for chronic pain. In the
development phase, knowledge of user characteristics that
are linked to greater improvements can be used to
enhance the efficacy of ACT through greater targeting of
treatment toward those characteristics.
The IPD-database of this project is conceptualized
as a basis for other MAs to come in the future. As
not all research questions might be answerable due
to the unavailability of the current evidence, this
project is designed as a long-term project in which
we will continuously update the IPD-database and
subsequently provide more in-depth analyses on the
effectiveness of ACT in chronic pain patients. Diffe-
rent researchers within the collaborative network of
this project can investigate different specific research
questions. For example, more knowledge on treat-
ment processes within ACT and patient characteris-
tics can be an essential step forward to improve
treatment effects for chronic pain [96–105]. The col-
laborative structure of this project will also stimulate
scientific exchange between experts in the field
which might generate ideas for methods to improve
future trials or treatment development.
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